본문으로 바로가기

의료진 소개

편욱범 의사

편욱범 교수

순환기내과, 심혈관센터 관심의료진 등록

전문 진료 분야

고혈압, 중재시술, 급성 심근경색증, 협심증

진료 일정

학력사항

  • 연세대학교 의과대학 졸업
  • 연세대학교 대학원 석사 학위 취득
  • 연세대학교 대학원 박사 학위 취득

교육 및 연구경력

  • 2019-2020  | 이대서울병원 병원장
  • 이화여자대학교 의과대학 교수
  • 인제대학교 일산백병원 심장혈관센터 조교수
  • 연세대학교 심장혈관병원 전임의

기타 학술 관련 경력

  • 대한고혈압학회 이사장
  • 대한심장학회 KCJ 편집위원
  • 대한심장학회, 대한고혈압학회, 대한중재시술학회

논문

  •  Association of long-term exposure to PM2.5 and survival following ischemic heart disease.  Environmental Research. 2023, v.216, 114440. 
  •  Efficacy and Safety of 3 Versus 6 Months of Dual-Antiplatelet Therapy in Patients Implanted With Coroflex ISAR Stents: A Prospective, Multicenter, Randomized Clinical Trial.  JOURNAL OF INVASIVE CARDIOLOGY. 2022, v.34 no.9, E653-. 
  •  Elevated On-Treatment Diastolic Blood Pressure and Cardiovascular Outcomes in the Presence of Achieved Systolic Blood Pressure Targets.  Korean Circulation Journal. 2022, v.52 no.6, 460-474. 
  •  Rivaroxaban Once-Daily vs. Dose-Adjusted Vitamin K Antagonist on Biomarkers in Acute Decompensated Heart Failure and Atrial Fibrillation (ROAD HF-AF): Rationale and Design of an Investigator-Initiated Multicenter Randomized Prospective Open-Labeled Pilot Clinical Study.  FRONTIERS IN CARDIOVASCULAR MEDICINE. 2022, v.8, 765081. 
  •  A Randomized, Double-blind, Active-controlled, Two Parallel-Group, Optional Titration, Multicenter, Phase IIIb Study to Evaluate the Efficacy and Safety of Fimasartan Versus Perindopril Monotherapy With and Without a Diuretic Combination in Elderly Patients With Essential Hypertension.  CLINICAL THERAPEUTICS. 2021, v.43 no.10, 1746-1756. 
  •  Antihypertensive Drugs and the Risk of Cancer: A Nationwide Cohort Study.  JOURNAL OF CLINICAL MEDICINE. 2021, v.10 no.4, 771. 
  •  Clinical features and predictors of masked uncontrolled hypertension from the Korean Ambulatory Blood Pressure Monitoring Registry.  KOREAN JOURNAL OF INTERNAL MEDICINE. 2021, v.36 no.5, 1102-. 
  •  Different therapeutic associations of renin-angiotensin system inhibitors with coronavirus disease 2019 compared with usual pneumonia.  Korean Journal of Internal Medicine. 2021, v.36 no.3, 617-628. 
  •  Disparities in Mortality and Cardiovascular Events by Income and Blood Pressure Levels Among Patients With Hypertension in South Korea.  JOURNAL OF THE AMERICAN HEART ASSOCIATION. 2021, v.10 no.7, e018446. 
  •  Effect of angiotensin receptor blockers on the development of cancer: A nationwide cohort study in korea.  Journal of Clinical Hypertension. 2021, v.23 no.4, 879-887. 
  •  Effect of short-term exposure to fine particulate matter and temperature on acute myocardial infarction in korea.  International Journal of Environmental Research and Public Health. 2021, v.18 no.9, 4822. 
  •  Intensive blood pressure lowering: a practical review.  Clinical Hypertension. 2021, v.27 no.1, 28-35. 
  •  Office Blood Pressure Range and Cardiovascular Events in Patients With Hypertension: A Nationwide Cohort Study in South Korea.  JOURNAL OF THE AMERICAN HEART ASSOCIATION. 2021, v.10 no.7, e017890. 
  •  Protective effect of controlled blood pressure on risk of dementia in low-risk, grade 1 hypertension.  JOURNAL OF HYPERTENSION. 2021, v.39 no.8, 1662-1669. 
  •  Smartphone / smartwatch-based cuffless blood pressure measurement : a position paper from the Korean Society of Hypertension.  Clinical Hypertension. 2021, v.27 no.2, 37-44. 
  •  Suboptimal Management Status of Younger Hypertensive Population in Korea.  KOREAN CIRCULATION JOURNAL. 2021, v.51 no.7, 598-606. 
  •  Blood pressure levels and cardiovascular risk according to age in patients with diabetes mellitus: a nationwide population-based cohort study.  Cardiovascular Diabetology. 2020, v.19 no.1, 181. 
  •  Clinical impact of pre-hypertension on the risk of cancer in male and female subjects.  Scientific Reports. 2020, v.10 no.1, 9974. 
  •  Is the use of RAS inhibitors safe in the current era of COVID-19 pandemic?.  Clinical Hypertension. 2020, v.26 no.3, 26-30. 
  •  2018 Korean Society of Hypertension Guidelines for the management of hypertension: part II-diagnosis and treatment of hypertension.  Clinical Hypertension. 2019, v.25 no.20, 1-24. 
  •  018 Korean Society of Hypertension guidelines for the management of hypertension: part I-epidemiology of hypertension.  Clinical Hypertension. 2019, v.25 no.16, 1-6. 
  •  2018 Korean society of hypertension guidelines for the management of hypertension: part III-hypertension in special situations.  Clinical Hypertension. 2019, v.25 no.19, 1-14. 
  •  Differential Control Rate of Systolic and Diastolic Blood Pressure among Korean Adults with Hypertension: the Sixth Korean National Health and Nutrition Examination Survey, 2013-2015 (KNHANES VI).  KOREAN CIRCULATION JOURNAL. 2019, v.49 no.11, 1035-1048. 
  •  Efficacy and Safety of Triple Therapy With Telmisartan, Amlodipine, and Rosuvastatin in Patients With Dyslipidemia and Hypertension: The Jeil Telmisartan, Amlodipine, and Rosuvastatin Randomized Clinical Trial.  CLINICAL THERAPEUTICS. 2019, v.41 no.2, 233-248. 
  •  Fimasartan versus perindopril with and without diuretics in the treatment of elderly patients with essential hypertension (Fimasartan in the Senior Subjects (FITNESS)): Study protocol for a randomized controlled trial.  Trials. 2019, v.20 no.1, 389. 
  •  Clinical Benefit of Treatment of Stage-1, Low-Risk Hypertension: Korean National Health Insurance Database Analysis.  HYPERTENSION. 2018, v.72 no.6, 1285-1293. 
  •  Development and clinical application of an evidence-based pharmaceutical care service algorithm in acute coronary syndrome.  JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS. 2018, v.43 no.3, 366-376. 
  • Dash R, Mitsutake Y, Pyun WB, Dawoud F, Lyons J, Tachibana A, Yahagi K, Matsuura Y, Kolodgie FD, Virmani R, McConnell MV, Illindala U, Ikeno F, Yeung A.. Dose-Dependent Cardioprotection of Moderate (32°C) Versus Mild (35°C) Therapeutic Hypothermia in Porcine Acute Myocardial Infarction.  JACC Cardiovasc Interv. 2018 Jan 22;11(2):195-205. doi: 10.1016/j.jcin.2017.08.056.. 
  • Mitsutake Y, Reifart J, Pyun WB, Lyons JK, Deuse T, Schrepfer S, Ikeno F. Differences in Vascular Response between Balloon Overstretch and Stent Overexpansion in Nonatherosclerotic Porcine Coronary Arteries..  Comp Med.. 2017 Aug 1;67(4):350-355.. 
  • Kang IS, Pyun WB, Shin J, Ihm SH, Kim JH, Park S, Kim KI, Kim WS, Kim SG, Shin GJ.. Higher Blood Pressure Variability in White Coat Hypertension; from the Korean Ambulatory Blood Pressure Monitoring Registry.  Korean Circ J. 2016 May;46(3):365-73. doi: 10.4070/kcj.2016.46.3.365. Epub 2016 Jan 18.. 
  • Kibbe MR, Hirsch AT, Mendelsohn FO, Davies MG, Pham H, Saucedo J, Marston W, Pyun WB, Min SK, Peterson BG, Comerota A, Choi D, Ballard J, Bartow RA, Losordo DW, Sherman W, Driver V, Perin EC. Safety and efficacy of plasmid DNA expressing two isoforms of hepatocyte growth factor in patients with critical limb ischemia..  Gene Ther. 2016 Apr;23(4):399. doi: 10.1038/gt.2016.9.. 
  • Kibbe MR, Hirsch AT, Mendelsohn FO, Davies MG, Pham H, Saucedo J, Marston W, Pyun WB, Min SK, Peterson BG, Comerota A, Choi D, Ballard J, Bartow RA, Losordo DW, Sherman W, Driver V, Perin EC.. Safety and efficacy of plasmid DNA expressing two isoforms of hepatocyte growth factor in patients with critical limb ischemia..  Gene Ther. 2016 Mar;23(3):306-12. doi: 10.1038/gt.2015.110. Epub 2015 Dec 8. . 
  • Kang IS, Fumiaki I, Pyun WB.. Therapeutic Hypothermia for Cardioprotection in Acute Myocardial Infarction..  Yonsei Med J. . 2016 Mar;57(2):291-7. doi: 10.3349/ymj.2016.57.2.291.. 
  • Rodseth RN, Biccard BM, Le Manach Y, Sessler DI, Lurati Buse GA, Thabane L, Schutt RC, Bolliger D, Cagini L, Cardinale D, Chong CP, Chu R, Cnotliwy M, Di Somma S, Fahrner R, Lim WK, Mahla E, Manikandan R, Puma F, Pyun WB, Radović M, Rajagopalan S, Suttie S, Vanniyasingam T, van Gaal WJ, Waliszek M, Devereaux PJ.. The prognostic value of pre-operative and post-operative B-type natriuretic peptides in patients undergoing noncardiac surgery: B-type natriuretic peptide and N-terminal fragment of pro-B-type natriuretic peptide: a systematic review and individual patient data meta-analysis..  J Am Coll Cardio. 2014 Jan 21;63(2):170-80. doi: 10.1016/j.jacc.2013.08.1630. Epub 2013 Sep 26. . 
  • Hahn W, Pyun WB, Kim DS, Yoo WS, Lee SD, Won JH, Shin GJ, Kim JM, Kim S.. Enhanced cardioprotective effects by coexpression of two isoforms of hepatocyte growth factor from naked plasmid DNA in a rat ischemic heart disease model..  J Gene Med. 2011 Oct;13(10):549-55. doi: 10.1002/jgm.1603.. 
  • Pyun WB, Hahn W, Kim DS, Yoo WS, Lee SD, Won JH, Rho BS, Park ZY, Kim JM, Kim S.. Naked DNA expressing two isoforms of hepatocyte growth factor induces collateral artery augmentation in a rabbit model of limb ischemia..  Gene Ther. 2010 Dec;17(12):1442-52. doi: 10.1038/gt.2010.101. Epub 2010 Jul 29..